Suchergebnisse - "De Ryck, Iris"

PubPharm (38)

11

Correction to: GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia

enthalten in: Infectious diseases and therapy | 2022

von De Ryck, I. | Sarakinou, E. | Nakakana, U. | +7

12

Correction to: GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia

enthalten in: Infectious diseases and therapy | 2022

von De Ryck, I. | Sarakinou, E. | Nakakana, U. | +7

13

GMMA Technology for the Development of Safe Vaccines : Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia

enthalten in: Infectious diseases and therapy | 2022

von De Ryck, I. | Sarakinou, E. | Nakakana, U. | +7

ErratumIn: Infect Dis Ther. 2022 Jun;11(3):1313. - PMID 35435576

14

The Pitfalls of Abnormal Laboratory Value Interpretation in Vaccine Clinical Trials : The Example of Asymptomatic Transient Neutropenia

enthalten in: Drugs in R&D | 2022

von Vella, V. | Schmidt, J. | Cilio, G. | +4

ErratumIn: Drugs R D. 2022 Sep;22(3):253. - PMID 35994226

15

GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia

enthalten in: Infectious diseases and therapy | 2022

von De Ryck, I. | Sarakinou, E. | Nakakana, U. | +7

16

GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia

enthalten in: Infectious diseases and therapy | 2022

von De Ryck, I. | Sarakinou, E. | Nakakana, U. | +7

17

GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia

enthalten in: Infectious diseases and therapy | 2022

von De Ryck, I. | Sarakinou, E. | Nakakana, U. | +7

18

The Pitfalls of Abnormal Laboratory Value Interpretation in Vaccine Clinical Trials: The Example of Asymptomatic Transient Neutropenia

enthalten in: Drugs in R & D | 2021

von Vella, V. | Schmidt, J. | Cilio, G. | +4

19

The Pitfalls of Abnormal Laboratory Value Interpretation in Vaccine Clinical Trials: The Example of Asymptomatic Transient Neutropenia

enthalten in: Drugs in R & D | 2021

von Vella, V. | Schmidt, J. | Cilio, G. | +4

20

The Pitfalls of Abnormal Laboratory Value Interpretation in Vaccine Clinical Trials: The Example of Asymptomatic Transient Neutropenia

enthalten in: Drugs in R & D | 2021

von Vella, V. | Schmidt, J. | Cilio, G. | +4